Back to search

Article

Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon Agonism

2024-09-19

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Heart failure with preserved ejection fraction (HFpEF) is a significant public health concern with limited treatment options. Dysregulated nitric oxide-mediated signaling has been implicated in HFpEF pathophysiology, however, little is known about the role of endogenous hydrogen sulfide (H 2 S) in HFpEF. <h4>Objectives</h4> This study evaluated H 2 S bioavailability in p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
97e7a205-b886-5af7-bd97-0a8f03565d56
DOI
10.1101/2024.09.16.613349
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon AgonismDOI 10.1101/2024.09.16.613349
Select a neighboring publication to make it the new centre.